Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data by Nils Kuklik, Jürgen Stausberg, Marjan Amiri, Karl-Heinz Jöckel

Subjects: Get full text

Controversies regarding lithium-associated weight gain: case–control study of real-world drug safety data by Waldemar Greil, Mateo de Bardeci, Bruno Müller-Oerlinghausen, Nadja Nievergelt, Hans Stassen, Gregor Hasler, Andreas Erfurth, Katja Cattapan, Eckart Rüther, Johanna Seifert, Sermin Toto, Stefan Bleich, Georgios Schoretsanitis

Subjects: Get full text

Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases by Nomura K, Takahashi K, Hinomura Y, Kawaguchi G, Matsushita Y, Marui H, Anzai T, Hashiguchi M, Mochizuki M

“…This study will help those concerned with pharmacovigilance better understand the use and pitfalls of using spontaneous AE data. Keywords: drug safety, spontaneous reports system, Japan, reporting disproportionality …”
Get full text

Importance of modelling hERG binding in predicting drug-induced action potential prolongations for drug safety assessment by Farm, HJ, Clerx, M, Cooper, F, Polonchuk, L, Wang, K, Gavaghan, DJ, Lei, CL

“…This study demonstrates the importance of modelling drug binding and highlights the need for improved understanding of drug trapping which can have implications for the uses in drug safety assessment.…”

Evaluation of droperidol use in the emergency department: a retrospective analysis of QTc prolongation and adverse events by Abdulmajeed M. Alshehri, Kaitlin E. Crowley, Kenneth E. Lupi, Christine S. Kim, Jeremy R. DeGrado, Kaylee Marino

Subjects: Get full text

Cholestatic hepatitis induced by atorvastatin: a case-report by M. Vergura, P. Tomaiuolo

Subjects: Get full text

Vaccine Safety Surveillance Systems: Critical Elements and Lessons Learned in the Development of the US Vaccine Safety Datalink’s Rapid Cycle Analysis Capabilities by Robert L. Davis

Subjects: “…vaccine safety, drug safety, surveillance…”
Get full text

Opportunities Missed, Warnings Ignored: Re-discovering the History of Drug Safety in Great Britain following the Thalidomide Disaster 1961 by Stuart Anderson

“…Following the thalidomide disaster1961 many accounts of pre-thalidomide drug safety history appeared. Some identified events which represented missed opportunities or ignored warning signs. …”
Get full text

Drug Safety Evaluation of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Comorbid Patients by Review of Systemic Extraglycemic Effects by Omari MB, Naseri S, Hassan AJ

Get full text

Drug safety: focus on long-term therapy with proton pump inhibitors. Possible cardiovascular risk and rare side effects by Dmitry I. Trukhan

Subjects: Get full text

Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active Pharmacovigilance by Anna Parzianello, Giulia Fornasier, Valentina Kiren, Federico Pigato, Sabrina Orzetti, Giulia Zamagni, Anna Arbo, Paolo Baldo, Paola Rossi, Marco Rabusin, Maurizio Mascarin, Marta Paulina Trojniak

Get full text

General Public Views, Attitudes, and Experiences toward Drug Safety in Dubai, United Arab Emirates: A Qualitative Approach by Doaa Alkhalidi, Shazia Qasim Jamshed, Ramadan Mohamed Elkalmi, Mirza Rafi Baig, Adeel Aslam, Mohamed Azmi Hassali

Subjects: Get full text

TREATMENT OF PATIENT SYNDROME AT THE AMBULATORY-POLYCLINIC STAGE. SELECTION OF THE ANALGETIC FROM THE POSITIONS OF COMORBIDITY AND DRUG SAFETY: IN FOCUS DEXKETOPROFEN by D. I. Trukhan, D. S. Ivanova

Subjects: Get full text

Drug Safety During Breastfeeding: A Comparative Analysis of FDA Adverse Event Reports and LactMed^® by Hülya Tezel Yalçın, Nadir Yalçın, Michael Ceulemans, Karel Allegaert

“…The FAERS database is useful to obtain exploratory information about ADEs during lactation to increase the knowledge about drug safety during breastfeeding and the awareness of the possible risks in nursing infants, while LactMed^® translates all available information into guidance.…”
Get full text

Results of a Sociological Survey on the Needs of Drug Safety Monitoring Specialists for Information on the Creation of the Pharmacovigilance System Master File by N. G. Goloenko, R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, M. V. Protsenko, D. G. Karapetyan

Get full text

Enhancing pharmacogenomic data accessibility and drug safety with large language models: a case study with Llama3.1 by Dan Li, Leihong Wu, Ying-Chi Lin, Ying-Chi Lin, Ho-Yin Huang, Ho-Yin Huang, Ebony Cotton, Qi Liu, Ru Chen, Ruihao Huang, Yifan Zhang, Joshua Xu

Get full text

Influence of inpatient withdrawal treatment on drug safety in alcohol use disorder — a quasi-experimental pre-post study by Sebastian Schröder, Martin Schulze Westhoff, Stefan Bleich, Henry Bode, Konstantin Fritz Jendretzky, Benjamin Krichevsky, Alexander Glahn, Johannes Heck

Subjects: Get full text

Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database by Mingming Yu, Lijun Zhou, Mengda Cao, Chunmei Ji, Yuanyi Zheng

Get full text

Operation Save the World from Adverse Drug Reactions: findings from a drug safety surveillance programme in Nigeria by Yohanna Kambai Avong, MPH, Bolajoko Jatau, MPH, Gbenga Ayodele Kayode, PhD, Blessing Ukpabi, MSc, Eunice Bosede Avong, MPH, James Okuma, MS, Dennis Mordi, MSc, Alash'le Abimiku, PhD, Obinna Ogbanufe, MPH, Charles Olalekan Mensah, MBA, Patrick Dakum, MPH

“…The drug safety surveillance programme runs in major public hospitals but is managed by the National Pharmacovigilance Center in collaboration with IHVN. …”
Get full text

Methods for drug safety signal detection using routinely collected observational electronic health care data: a systematic review by A. Sh. Motrinchuk, O. A. Loginovskaya, V. P. Kolbatov

Subjects: Get full text